Group B Streptococcal Infection - Symptoms, Causes, Treatment & Prevention

📅 Updated: May 2026 ⏱️ 6 min read ✅ Medically reviewed
Group B Streptococcal Infection – Comprehensive Medical Guide

Overview

Group B Streptococcus (GBS), also known as *Streptococcus agalactiae*, is a type of bacteria that normally lives in the gastrointestinal and genitourinary tracts of healthy adults. While most people carry GBS without any problems, it can cause serious infection when it spreads to sterile sites such as the bloodstream, lungs, or central nervous system.

GBS most commonly affects:

  • Newborn infants – especially during the first week of life (early‑onset disease) or up to three months (late‑onset disease).
  • Pregnant women – colonization can lead to urinary tract infection, chorioamnionitis, or pre‑term labor.
  • Adults with chronic medical conditions (diabetes, liver disease, HIV, cancer) or the elderly.

According to the U.S. Centers for Disease Control and Prevention (CDC), about 10–30% of pregnant women are colonized with GBS, and without preventive measures roughly 1–2% of newborns will develop invasive disease. Worldwide, the incidence of invasive GBS disease in infants is estimated at 0.5–1.0 cases per 1,000 live births (WHO, 2022).

Symptoms

Symptoms vary dramatically depending on the age of the patient, the site of infection, and the speed with which the bacteria spread.

Newborns and Infants

  • Early‑onset (first 0‑7 days) – fever, lethargy, poor feeding, difficulty breathing, apnea, irritability, or a limp “floppy” appearance.
  • Late‑onset (7 days‑3 months) – fever, seizures, irritability, poor weight gain, vomiting, meningitis signs (bulging fontanelle, stiff neck), or pneumonia.

Prenatal and Maternal Infection

  • Fever, chills, lower abdominal pain.
  • Foul‑smelling vaginal discharge or burning with urination (GBS urinary tract infection).
  • Pre‑term labor, ruptured membranes, or signs of chorioamnionitis (maternal fever, uterine tenderness).

Adults (especially those with comorbidities)

  • Fever, chills, and malaise.
  • Skin and soft‑tissue infection – redness, swelling, drainage.
  • Pneumonia – cough, chest pain, shortness of breath.
  • Urinary tract infection – dysuria, frequency.
  • Invasive disease – bloodstream infection (sepsis) leading to rapid heart rate, low blood pressure, confusion.
  • Meningitis – severe headache, neck stiffness, photophobia, altered mental status.

Causes and Risk Factors

GBS infection results from the bacteria entering a normally sterile part of the body. The primary reservoir is the gut and vagina, and transmission can be vertical (mother to baby) or horizontal (person‑to‑person, contaminated surfaces).

Key Risk Factors

  • Pregnancy – colonization rates peak during the third trimester.
  • Previous infant with GBS disease – recurrence risk increases to ~15%.
  • Prolonged rupture of membranes (>18 h) or intrapartum fever.
  • Pre‑term delivery (<37 weeks) – immature immune system.
  • Maternal conditions – diabetes, HIV infection, obesity, or urinary tract colonization.
  • Adult risk factors – chronic liver disease, diabetes mellitus, alcoholism, cancer, immunosuppressive therapy, or advanced age.
  • Hospital exposure – especially intensive‑care units, indwelling catheters, or recent surgery.

Diagnosis

Accurate diagnosis hinges on clinical suspicion combined with laboratory testing.

Screening in Pregnancy

  • Universal culture – a rectovaginal swab performed at 35‑37 weeks gestation; results guide intrapartum antibiotic prophylaxis (IAP). Sensitivity ≈ 90% (CDC, 2020).

Diagnostic Tests for Symptomatic Patients

  1. Blood cultures – gold standard for bacteremia and sepsis.
  2. Lumbar puncture – cerebrospinal fluid (CSF) analysis for meningitis (elevated white cells, low glucose, high protein); CSF culture confirms GBS.
  3. Urine culture – detects urinary tract infection.
  4. Chest X‑ray or CT – evaluate pneumonia or empyema.
  5. Wound or pus culture – for skin/soft‑tissue infection.
  6. Polymerase chain reaction (PCR) – rapid detection in blood or CSF, increasingly used in neonatal labs.

Laboratory Findings

  • Elevated white blood cell count, C‑reactive protein, or procalcitonin.
  • In newborns, a left‑shift (increase in immature neutrophils) is common.

Treatment Options

Prompt antimicrobial therapy is essential. Treatment choice depends on patient age, disease severity, and antibiotic susceptibility.

First‑Line Antibiotics

  • PENICILLIN G – preferred for neonates and pregnant women (dose 50,000 U/kg IV every 12 h for < 7 days).
  • AMPICILLIN – for adults with mild‑moderate infection (typically 1‑2 g IV every 4–6 h).
  • CEFTRIAXONE – alternative for penicillin‑allergic patients; 50‑75 mg/kg IV q12h in neonates.

Adjunctive Therapies

  • Intravenous fluids – for sepsis or dehydration.
  • Supportive care – oxygen, mechanical ventilation if respiratory failure develops.
  • Antiepileptic drugs – for seizures in meningitis.

Duration of Therapy

ConditionTypical Duration
Early‑onset neonatal sepsis10‑14 days
Late‑onset neonatal meningitis21‑28 days
Adult bacteremia without focus14 days
Skin/soft‑tissue infection7‑10 days (may shift to oral)

Lifestyle & Supportive Measures

  • Adequate hydration and nutrition during treatment.
  • Prompt removal of invasive devices (e.g., urinary catheters) when no longer needed.
  • Close monitoring of temperature, mental status, and wound healing.

Living with Group B Streptococcal Infection

For individuals who have experienced GBS infection—or who are colonized—daily management focuses on preventing recurrence and monitoring for complications.

Key Self‑Care Strategies

  • Adhere to antibiotic regimens exactly as prescribed; never stop early even if you feel better.
  • Maintain good hygiene – wash hands frequently, especially after using the bathroom or before handling food.
  • Regular follow‑up – attend post‑treatment appointments for repeat cultures when indicated (e.g., after pregnancy).
  • Monitor for signs of recurrence – fever, unexplained fatigue, new skin lesions, or urinary symptoms.
  • Vaccination updates – while no GBS vaccine is yet licensed, staying current with influenza and pneumococcal vaccines reduces overall respiratory infection risk.
  • For pregnant women, inform all caregivers about GBS status so intrapartum antibiotics can be administered.

Psychosocial Considerations

Having a serious bacterial infection can cause anxiety, especially for new parents. Access to counseling, support groups (e.g., March of Dimes networks), and reliable information can alleviate stress.

Prevention

Because most GBS carriers are asymptomatic, prevention relies on targeted medical interventions and general infection‑control practices.

For Pregnant Women

  1. Universal screening at 35‑37 weeks (CDC recommendation).
  2. Intrapartum antibiotic prophylaxis (IAP) – usually penicillin G administered every 4 hours during labor if colonized or if GBS status unknown and risk factors present.
  3. Consider repeat testing if a previous pregnancy was complicated by GBS disease.

General Population

  • Hand hygiene—wash with soap and water for at least 20 seconds.
  • Proper wound care – keep cuts clean, covered, and seek medical attention for signs of infection.
  • Avoid sharing personal items (towels, razors) that may be contaminated.
  • Limit unnecessary catheter use; prompt removal when no longer needed.

Future Prevention Strategies

Multiple phase‑III trials are evaluating a conjugate GBS vaccine for pregnant women, which could dramatically lower neonatal disease rates (NIH, 2023). Until a vaccine is available, adherence to current screening and IAP protocols remains the most effective preventive measure.

Complications

If not recognized early, GBS can lead to severe, life‑threatening outcomes.

In Neonates

  • Septic shock and multi‑organ failure.
  • Permanent neurological damage from meningitis (hearing loss, cerebral palsy).
  • Respiratory failure due to pneumonia or pulmonary hemorrhage.

In Adults

  • Endocarditis – infection of heart valves.
  • Osteomyelitis – bone infection, especially in diabetics.
  • Necrotizing fasciitis – rapidly spreading soft‑tissue infection.
  • Persistent bacteremia leading to septic emboli in lungs, brain, or kidneys.

Overall mortality for invasive GBS disease in adults ranges from 5% to 20% depending on comorbidities and timeliness of treatment (Cleveland Clinic, 2022).

When to Seek Emergency Care

Call 911 or go to the nearest emergency department immediately if you (or your child) experience any of the following:
  • High fever (≥38.5 °C or 101.3 °F) that does not respond to acetaminophen or ibuprofen.
  • Severe shortness of breath, rapid breathing, or bluish lips/face.
  • Sudden change in mental status – confusion, drowsiness, seizures, or inability to wake.
  • Rapid heart rate (>120 beats/min) combined with low blood pressure (systolic <90 mmHg).
  • Persistent vomiting or inability to keep fluids down.
  • New rash with purpura, petechiae, or spreading redness around a wound.
  • Neonatal signs: limpness, poor feeding, high-pitched cry, or breathing pauses.

These signs may indicate sepsis, meningitis, or severe pneumonia, all of which require immediate medical intervention.

References

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References